NO. Gender Underlying diseases Age at transplant, months Graft type Age at donor, months donor-recipient ABO blood group Conditioning regimen GVHD prophylaxis Graft source donor-recipient HLA match MNC counts(X10^8/KG) CD34+ counts(X10^6/KG) neutrophil engraftment time platelet engraftment time
1 F AA 63 HLA-matched sibling 5 O+/O+ Bu/Cy/Flu/ATG CsA PBSC 10 8.38 5.17 11 25
2 F AML 167 Haploidentical 28 O+/O+ Bu/Cy/ATG PTCy PBSC 5 17.7 20.05 19 14
3 M MPS 39 (9/10)HLA-matched unrelated 0 O+/A+ Bu/Cy/Flu/ATG CsA/MMF CB 9 0.821 0.353 22 39
4 M AML 174 (9/10)HLA-matched unrelated 29 O+/B+ Bu/Cy/ATG CsA/MMF/MTX PBSC 9 7.4 7.1 12 12
5 M ALL 72 Haploidentical 27 A+/O+ Bu/Cy/Flu/ATG PTCy PBSC 5 26.06 23.6 14 9
6 M HLH 35 Haploidentical 32 A+/O+ Bu/Cy/Flu/ATG/VP-16 CsA/MMF/MTX PBSC 7 7.97 4.64 19 37
7 F MDS 159 Haploidentical 6 B+/B+ Bu/Cy/Flu/ATG PTCy PBSC 5 27.04 14.27 16 11
8 M HLH 153 Haploidentical 39 B+/O+ Bu/Cy/Flu/ALG CsA/MMF/MTX BM+PBSC 8 8.25 7.25 Non-engraftment Non-engraftment
9 F AA 50 Haploidentical 33 A+/A+ Bu/Cy/Flu/ATG CsA/MMF/MTX PBSC 9 8.29 3.62 15 15
10 F AA 146 Haploidentical 39 A+/AB+ Bu/Cy/Flu/ATG CsA/MMF/MTX PBSC 7 7.5 8.65 12 17
11 F AA 29 (9/10)HLA-matched unrelated 22 O+/AB+ Bu/Cy/Flu/ATG CsA/MMF/MTX PBSC 9 7.4 9.4 15 34
12 M HLH 163 Haploidentical 5 A+/O+ Bu/Cy/Flu/ATG/VP-16 KF506/MMF/MTX PBSC 5 7.85 5.8 18 23
13 M MPAL 105 Haploidentical 42 A+/O+ Bu/Cy/Flu/ATG PTCy PBSC 6 31.89 13.52 15 15
14 F FA 10 (9/10)HLA-matched unrelated 28 B+/0+ Bu/Cy/Flu/ATG CsA/MMF PBSC 9 7.4 6.2 10 7
15 F AML 182 Haploidentical 38 B/AB Bu/Cy/Flu/ATG PTCy PBSC 5 33.9 13.25 17 15
16 M AML 145 Haploidentical 34 AB/A Bu/Cy/Flu/ATG PTCy PBSC 5 39.6 14.17 19 22
17 M AA 190 Haploidentical 41 A+/A+ Bu/Cy/Flu/ATG CsA/MMF/MTX PBSC 5 7.98 5.12 15 17
18 M MS 100 Haploidentical 39 B/AB TBI/Bu/Cy/Flu/ATG PTCy PBSC 6 35.99 17.92 13 11
19 F AA 170 Haploidentical 19 O+/O+ Bu/Cy/Flu/ATG CsA/MMF PBSC 5 8.38 4 16 17
20 M AML 175 Haploidentical 42 A+/O+ Bu/Cy/Flu/ATG PTCy PBSC 6 32.2 14.1 16 16